Point72 Middle East FZE’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-28,135
Closed -$3.65M 19
2023
Q4
$3.65M Buy
+28,135
New +$3.88M 0.11% 255
2023
Q3
Sell
-4,548
Closed -$834K 1397
2023
Q2
$834K Buy
4,548
+4,298
+1,719% +$619K 0.02% 640
2023
Q1
$33.3K Buy
+250
New +$29.4K ﹤0.01% 1345

Other funds holding ACLS

Point72 Middle East FZE's ACLS Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 28,135 shares — an estimated $3.65M sold.

Point72 Middle East FZE first reported a position in ACLS in Q1 2023 and held it in 3 quarters. The position peaked at $3.65M in Q4 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 28,135 Axcelis shares in Q1 2024, an estimated $3.65M.
  • Point72 Middle East FZE first reported a position in Axcelis in Q1 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's Axcelis position peaked at $3.65M in Q4 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.